[HTML][HTML] Opportunities and challenges for human papillomavirus vaccination in cancer
R Roden, PL Stern - Nature Reviews Cancer, 2018 - nature.com
The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
[HTML][HTML] Vaccine delivery using nanoparticles
AE Gregory, R Titball, D Williamson - Frontiers in cellular and …, 2013 - frontiersin.org
Vaccination has had a major impact on the control of infectious diseases. However, there
are still many infectious diseases for which the development of an effective vaccine has …
are still many infectious diseases for which the development of an effective vaccine has …
Correlates of protection induced by vaccination
SA Plotkin - Clinical and vaccine immunology, 2010 - Am Soc Microbiol
This paper attempts to summarize current knowledge about immune responses to vaccines
that correlate with protection. Although the immune system is redundant, almost all current …
that correlate with protection. Although the immune system is redundant, almost all current …
[HTML][HTML] Papillomaviruses and cancer: from basic studies to clinical application
H Zur Hausen - Nature reviews cancer, 2002 - nature.com
Links between human papillomaviruses (HPVs) and cervical cancer were first suspected
almost 30 years ago. DNA of specific HPV types has since been found in almost all cervical …
almost 30 years ago. DNA of specific HPV types has since been found in almost all cervical …
Epithelial cell responses to infection with human papillomavirus
MA Stanley - Clinical microbiology reviews, 2012 - Am Soc Microbiol
Human papillomavirus (HPV) infection of the genital tract is common in young sexually
active individuals, the majority of whom clear the infection without overt clinical disease …
active individuals, the majority of whom clear the infection without overt clinical disease …
[HTML][HTML] Explanations for the high potency of HPV prophylactic vaccines
J Schiller, D Lowy - Vaccine, 2018 - Elsevier
HPV L1 virus-like particle (VLP) vaccines administered in a prime/boost series of three
injections over six months have demonstrated remarkable prophylactic efficacy in clinical …
injections over six months have demonstrated remarkable prophylactic efficacy in clinical …
[HTML][HTML] Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label …
D Watson-Jones, J Changalucha… - The Lancet Global …, 2022 - thelancet.com
Background An estimated 15% of girls aged 9–14 years worldwide have been vaccinated
against human papillomavirus (HPV) with the recommended two-dose or three-dose …
against human papillomavirus (HPV) with the recommended two-dose or three-dose …
[HTML][HTML] Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
R Sankaranarayanan, PR Prabhu, M Pawlita… - The lancet …, 2016 - thelancet.com
Background An increase in worldwide HPV vaccination could be facilitated if fewer than
three doses of vaccine are as effective as three doses. We originally aimed to compare the …
three doses of vaccine are as effective as three doses. We originally aimed to compare the …
[HTML][HTML] Recent developments in human papillomavirus (HPV) vaccinology
AL Williamson - Viruses, 2023 - mdpi.com
Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …